Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 9/20 | 0.58 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.47 |
| ▸ | BMP1 | P13497 | 1/20 | 0.46 |
| ▸ | MME | P08473 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 2/20 | 0.44 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.44 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.43 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29893864 | 1.00 | FOLH1 (0.58) | FOLH1NAALAD2BMP1MMEALDH1A1 | |
| SCHEMBL29892709 | 0.95 | FOLH1 (0.53) | FOLH1BACE1 | |
| SCHEMBL31097671 | 0.95 | FOLH1 (0.52) | FOLH1BMP1BACE1BACE2 | |
| SCHEMBL31097664 | 0.95 | FOLH1 (0.52) | FOLH1BMP1BACE1BACE2 | |
| SCHEMBL31097672 | 0.95 | FOLH1 (0.52) | FOLH1BMP1BACE1BACE2 | |
| SCHEMBL31097707 | 0.95 | FOLH1 (0.52) | FOLH1BMP1BACE1BACE2 | |
| SCHEMBL31097688 | 0.92 | FOLH1 (0.53) | FOLH1NAALAD2BMP1BACE1BACE2 | |
| SCHEMBL31097708 | 0.92 | FOLH1 (0.53) | FOLH1NAALAD2BMP1BACE1BACE2 | |
| SCHEMBL31097687 | 0.92 | FOLH1 (0.53) | FOLH1NAALAD2BMP1BACE1BACE2 | |
| SCHEMBL30527800 | 0.92 | FOLH1 (0.53) | FOLH1NAALAD2BMP1BACE1BACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12129277-B2 | Linear solution phase routes for WNT hexapeptides | WNTRESEARCH AB (SE) | 2024-10-29 | — | — | US | disclosed |
| CN-112638934-B | Solution phase Path for WNT hexapeptide | 温特研究公司 | 2024-06-11 | — | — | CN | disclosed |
| US-11970551-B2 | Solution phase routes for WNT hexapeptides | WNTRESEARCH AB (SE) | 2024-04-30 | — | — | US | disclosed |
| CN-113646324-B | Linear solution phase pathway for WNT hexapeptide | 温特研究公司 | 2024-03-29 | — | — | CN | disclosed |
| US-11912791-B2 | Solution phase routes for Wnt hexapeptides | WNTRESEARCH AB (SE) | 2024-02-27 | — | — | US | disclosed |
| US-20230295232-A1 | SOLUTION PHASE ROUTES FOR WNT HEXAPEPTIDES | WNTRESEARCH AB (SE) | 2023-09-21 | — | — | US | disclosed |
| EP-3841107-B1 | SOLUTION PHASE ROUTES FOR WNT HEXAPEPTIDES | WNTRESEARCH AB (SE) | 2023-06-28 | — | — | EP | disclosed |
| EP-3894426-B1 | LINEAR SOLUTION PHASE ROUTES FOR WNT HEXAPEPTIDES | WNTRESEARCH AB (SE) | 2022-09-21 | — | — | EP | disclosed |